Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients

Cancer

Volumn 56, Issue 4, 1985, Pages 918-928

  Okuda, Kunio ^a   Ohtsuki, Toshio ^a   Obata, Hiroshi ^b   Tomimatsu, Masahiko ^b   Okazaki, Nobuo ^c   Hasegawa, Hiroshi ^c   Nakajima, Yukio ^a   Ohnishi, Kunihiko ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MITOMYCIN; PICIBANIL; SERUM ALBUMIN; TEGAFUR;

ASCITES; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; JAUNDICE; LIVER; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; THERAPY; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COMPARATIVE STUDY; EMBOLIZATION, THERAPEUTIC; FEMALE; FLUOROURACIL; HUMAN; LIVER NEOPLASMS; MALE; MIDDLE AGE; MITOMYCIN; MITOMYCINS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TEGAFUR; TIME FACTORS;

EID: 0021965806     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E     Document Type: Article

References (65)

1. Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies
2. Pathology of hepatocellular carcinoma
3. Pathology of hepatocellular carcinoma in Japan: Two hundred thirty‐two consecutive cases autopsied in 10 years
4. Epidemiology of primary liver cancer
5. Hepatocellular carcinoma in rural southern African blacks
6. Cancer mortality in China
7. Cirrhosis and primary cancer of the liver: Comparative study in Tokyo and Cincinnati
8. Primary carcinoma of the liver: A study of 282 cases in Ugandan Africans
9. Clinicopathological studies of minute hepatocellular carcinoma: Analysis of 20 cases, including 4 with hepatic resection
10. Small hepatocellular carcinoma: A clinicopathological study in thirteen patients
11. Diagnostic and clinical features of small hepatocellular carcinoma with emphasis on the utility of real‐time ultrasonography: A study of 51 patients
12. Carcinoma of the liver: A study of twenty‐eight cases
13. Roentgenologic diagnosis of primary carcinoma of the liver
14. Angiography of primary liver cancer
15. Angiographic assessment of gross anatomy of hepatocellular carcinoma: Comparison of celiac angiograms and liver pathology in 100 cases
16. Transcatheter embolization of hepatocellular carcinoma: Assessment of efficacy in cases of resection following embolization
17. Hepatic artery embolization in 120 patients with unresectable hepatoma
18. Hepatic arterial embolization for hepatocellular carcinoma: Comparison of CT scans and resected specimens
19. Arterial chemoembolization with microencapsulated anticancer drug: An approach to selective cancer chemotherapy with sustained effects
20. Clinical studies on cell‐mediated immunity in patients with malignant disease: I. Effect of immunotherapy with OK‐432 on lymphocyte subpopulation and phytomictogen responsiveness in vitro
21. Clinical value of immunotherapy for lung cancer by the Streptococcal preparation OK‐432
22. Results of treatment of malignant tumors with ftorafur
23. Phase I study of ftorafur, an analog of 5‐fluorouracil
24. Clinical studies of rectal administration of tegafur
25. Maximum utilization of the life table method in analyzing survival
26. Primary malignant tumors of the liver
27. A staging system for hepatocellular carcinoma: Prognostic factors in Ugandan patients
28. Chemotherapy studies in primary liver cancer: A prospective randomized clinical trial
29. Clinical features of hepatocellular carcinoma: Review of 211 patients in Hong Kong
30. Hepatocellular carcinoma: Polygonal cell type with fibrous stroma. An atypical variant with a favorable prognosis
31. Minute hepatocellular carcinoma without appreciable change in size for 7 years: A case report
32. Spontaneous regression of hepatocellular carcinoma
33. Spontaneous regression of hepatocellular carcinoma
34. International Symposium on Hepatocellular Carcinoma, Kampala, Uganda (July 1971)
35. Cancer of the liver and cirrhosis in trans‐Saharan Africa and the United States of America
36. Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: Evidence from Southern Africa
37. Gross anatomical features of hepatocellular carcinoma from three disparate geographic areas: Proposal of new classification
38. Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma
39. Evaluation of hepatic dearterialization in primary and secondary cancer of the liver
40. Clinical manifestations of hepatoma: A review of 6 years' experience at a cancer hospital
41. Detection of hepatocellular carcinoma during a clinical follow‐up of chronic liver disease: Observations in 31 patients
42. The Liver Cancer Study Group of Japan. Primary liver cancers in Japan
43. Primary liver cancers in Japan. Report 5
44. Experience with 150 liver resections
45. Factors influencing primary liver cancer resection survival rate
46. Resection of primary solid hepatic tumors
47. Clinical aspects of primary carcinoma of the liver
48. 5‐Fluorouracil in hepatocellular carcinoma: Report of 21 cases
49. A phase II study of Adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States
50. Induction of remission in hepatocellular carcinoma with doxorubicin
51. Further experience in treating patients with hepatocellular carcinoma in Uganda
52. The superselective and the selective one shot methods for treating inoperable cancer of the liver
53. Hepatic artery infusion chemotherapy in hepatoma
54. Primary liver cancer: A review of the clinical features, blood groups, serum enzymes, therapy, and survival of 65 cases
55. Clinicopathological features of encapsulated hepatocellular carcinoma: A study of 26 cases
56. Analysis of liver transplantation
57. The Cambridge and King's College Hospital experience of liver transplantation, 1968–1983